Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 1,853 | 2,529 | 491 | 66 | 101 |
| Operating Income | -1,853 | -2,529 | -491 | -66 | -101 |
| Interest Expense | 296 | 243 | 231 | 208 | 204 |
| Other Income | -90 | 364,614 | -392 | 484 | -59 |
| Pre-tax Income | -2,239 | 361,843 | -1,114 | 210 | -364 |
| Net Income Continuous | -2,239 | 250,293 | -1,114 | 210 | -364 |
| Minority Interests | -46 | -55 | -67 | -67 | -66 |
| Net Income | $-2,194 | $250,348 | $-1,047 | $278 | $-299 |
| EPS Basic Continuous Ops | -0.01 | 0.59 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.59 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.59 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-1,708 | $-2,466 | $-437 | $-24 | $-62 |